Differentially Expressed miRNAs in Ewing Sarcoma Compared to Mesenchymal Stem Cells: Low miR-31 Expression with Effects on Proliferation and Invasion
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Differentially Expressed miRNAs in Ewing Sarcoma Compared to Mesenchymal Stem Cells: Low miR-31 Expression with Effects on Proliferation and Invasion
Authors
Keywords
MicroRNAs, Ewing sarcoma, Biopsy, Mesenchymal stem cells, Gene expression, Transfection, Apoptosis, Cell staining
Journal
PLoS One
Volume 9, Issue 3, Pages e93067
Publisher
Public Library of Science (PLoS)
Online
2014-03-26
DOI
10.1371/journal.pone.0093067
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A TARBP2-Dependent miRNA Expression Profile Underlies Cancer Stem Cell Properties and Provides Candidate Therapeutic Reagents in Ewing Sarcoma
- (2012) Claudio De Vito et al. CANCER CELL
- Polycomb-Mediated Loss of miR-31 Activates NIK-Dependent NF-κB Pathway in Adult T Cell Leukemia and Other Cancers
- (2012) Makoto Yamagishi et al. CANCER CELL
- MetastamiRs: Non-Coding MicroRNAs Driving Cancer Invasion and Metastasis
- (2012) Cesar Lopez-Camarillo et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- An integrated analysis of miRNA and gene copy numbers in xenografts of Ewing's sarcoma
- (2012) Neda Mosakhani et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Tumor suppressive microRNAs (miR-222 and miR-31) regulate molecular pathways based on microRNA expression signature in prostate cancer
- (2012) Miki Fuse et al. JOURNAL OF HUMAN GENETICS
- EWS/FLI1 Regulates EYA3 in Ewing Sarcoma via Modulation of miRNA-708, Resulting in Increased Cell Survival and Chemoresistance
- (2012) T. P. Robin et al. MOLECULAR CANCER RESEARCH
- Antagonism Pattern Detection between MicroRNA and Target Expression in Ewing’s Sarcoma
- (2012) Loredana Martignetti et al. PLoS One
- miR-34a predicts survival of Ewing's sarcoma patients and directly influences cell chemo-sensitivity and malignancy
- (2011) Fumihiko Nakatani et al. JOURNAL OF PATHOLOGY
- Hsa-mir-145 is the top EWS-FLI1-repressed microRNA involved in a positive feedback loop in Ewing's sarcoma
- (2011) J Ban et al. ONCOGENE
- A novel oncogenic mechanism in Ewing sarcoma involving IGF pathway targeting by EWS/Fli1-regulated microRNAs
- (2011) E L McKinsey et al. ONCOGENE
- Risk of recurrence and survival after relapse in patients with Ewing sarcoma
- (2011) Martin Stahl et al. PEDIATRIC BLOOD & CANCER
- Modeling Initiation of Ewing Sarcoma in Human Neural Crest Cells
- (2011) Cornelia von Levetzow et al. PLoS One
- Let-7a Is a Direct EWS-FLI-1 Target Implicated in Ewing's Sarcoma Development
- (2011) Claudio De Vito et al. PLoS One
- Molecular Profiling Uncovers a p53-Associated Role for MicroRNA-31 in Inhibiting the Proliferation of Serous Ovarian Carcinomas and Other Cancers
- (2010) C. J. Creighton et al. CANCER RESEARCH
- EWS-FLI-1 modulates miRNA145 and SOX2 expression to initiate mesenchymal stem cell reprogramming toward Ewing sarcoma cancer stem cells
- (2010) N. Riggi et al. GENES & DEVELOPMENT
- Pro-tumorigenic Effects of miR-31 Loss in Mesothelioma
- (2010) Sergey V. Ivanov et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Impact ofEWS-ETSFusion Type on Disease Progression in Ewing's Sarcoma/Peripheral Primitive Neuroectodermal Tumor: Prospective Results From the Cooperative Euro-E.W.I.N.G. 99 Trial
- (2010) Marie-Cecile Le Deley et al. JOURNAL OF CLINICAL ONCOLOGY
- Metastamirs: a stepping stone towards improved cancer management
- (2010) Nicole M. A. White et al. Nature Reviews Clinical Oncology
- Recent advances in the molecular pathogenesis of Ewing's sarcoma
- (2010) E C Toomey et al. ONCOGENE
- Downregulation of miR-205 and miR-31 confers resistance to chemotherapy-induced apoptosis in prostate cancer cells
- (2010) N Bhatnagar et al. Cell Death & Disease
- RETRACTED: A Pleiotropically Acting MicroRNA, miR-31, Inhibits Breast Cancer Metastasis
- (2009) Scott Valastyan et al. CELL
- Concomitant suppression of three target genes can explain the impact of a microRNA on metastasis
- (2009) Scott Valastyan et al. GENES & DEVELOPMENT
- Causes and consequences of microRNA dysregulation in cancer
- (2009) Carlo M. Croce NATURE REVIEWS GENETICS
- EZH2 is a mediator of EWS/FLI1 driven tumor growth and metastasis blocking endothelial and neuro-ectodermal differentiation
- (2009) G. H. S. Richter et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- EWS-FLI-1 Expression Triggers a Ewing's Sarcoma Initiation Program in Primary Human Mesenchymal Stem Cells
- (2008) N. Riggi et al. CANCER RESEARCH
- Most mammalian mRNAs are conserved targets of microRNAs
- (2008) R. C. Friedman et al. GENOME RESEARCH
- MiRNA expression in urothelial carcinomas: Important roles of miR-10a, miR-222, miR-125b, miR-7 and miR-452 for tumor stage and metastasis, and frequent homozygous losses of miR-31
- (2008) Srinivas Veerla et al. INTERNATIONAL JOURNAL OF CANCER
- Results of the EICESS-92 Study: Two Randomized Trials of Ewing's Sarcoma Treatment—Cyclophosphamide Compared With Ifosfamide in Standard-Risk Patients and Assessment of Benefit of Etoposide Added to Standard Treatment in High-Risk Patients
- (2008) Michael Paulussen et al. JOURNAL OF CLINICAL ONCOLOGY
- Changes in Incidence and Survival of Ewing Sarcoma Patients Over the Past 3 Decades
- (2008) Natia Esiashvili et al. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started